Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Szalay Aladar | 10% Owner | Sep 12 '24 | Sale | 2.73 | 31,777 | 86,732 | 632,901 | Sep 13 06:22 PM | Szalay Aladar | 10% Owner | Sep 13 '24 | Sale | 2.57 | 33,080 | 84,946 | 599,821 | Sep 13 06:22 PM | Tyree James L | Director | Sep 11 '24 | Sale | 2.60 | 1,730 | 4,499 | 47,521 | Sep 12 08:40 PM | Szalay Aladar | 10% Owner | Sep 11 '24 | Sale | 2.62 | 31,376 | 82,227 | 664,678 | Sep 11 06:23 PM | Szalay Aladar | 10% Owner | Sep 09 '24 | Sale | 2.70 | 23,383 | 63,200 | 716,438 | Sep 11 06:23 PM | Szalay Aladar | 10% Owner | Sep 10 '24 | Sale | 2.51 | 20,384 | 51,182 | 696,054 | Sep 11 06:23 PM | JAMES L TYREE | Director | Sep 11 '24 | Proposed Sale | 2.51 | 1,730 | 4,342 | | Sep 11 04:20 PM | SZALAY 2010 RETAINED ANNUITY T | 10% Owner | Sep 09 '24 | Proposed Sale | 2.80 | 140,000 | 392,000 | | Sep 06 07:00 PM | Szalay Aladar | 10% Owner | Sep 03 '24 | Sale | 2.09 | 42,818 | 89,614 | 739,821 | Sep 06 05:08 PM | Szalay Aladar | 10% Owner | Aug 30 '24 | Sale | 2.17 | 142,589 | 309,846 | 782,639 | Aug 30 07:58 PM | Szalay Aladar | 10% Owner | Aug 29 '24 | Sale | 1.98 | 107,045 | 211,960 | 925,228 | Aug 30 07:58 PM | Szalay Aladar | 10% Owner | Aug 28 '24 | Sale | 2.05 | 15,918 | 32,605 | 1,032,273 | Aug 30 07:58 PM | Szalay Aladar | 10% Owner | Aug 27 '24 | Sale | 2.11 | 51,630 | 108,862 | 1,048,191 | Aug 27 07:23 PM | Szalay Aladar | 10% Owner | Aug 23 '24 | Sale | 2.29 | 40,000 | 91,416 | 1,099,821 | Aug 27 07:23 PM | SZALAY 2010 RETAINED ANNUITY T | 10% Owner | Aug 23 '24 | Proposed Sale | 2.18 | 400,000 | 872,000 | | Aug 22 05:08 PM | Yu Yong | VP, Clinical Trial Operations | Jun 24 '24 | Sale | 2.12 | 6,849 | 14,520 | 10,869 | Jul 08 04:30 PM | Ryder Sean | General Counsel | Jun 24 '24 | Sale | 2.12 | 5,496 | 11,652 | 19,388 | Jul 08 04:30 PM | Jewett Caroline | Head of Quality | Jun 24 '24 | Sale | 2.12 | 4,961 | 10,517 | 16,174 | Jul 08 04:30 PM | Szalay Aladar | 10% Owner | May 15 '24 | Sale | 3.66 | 17,094 | 62,624 | 1,139,821 | May 15 05:59 PM | Szalay Aladar | 10% Owner | May 14 '24 | Sale | 3.58 | 15,426 | 55,274 | 1,156,915 | May 15 05:59 PM | Szalay Aladar | 10% Owner | May 13 '24 | Sale | 3.62 | 3,446 | 12,478 | 1,172,341 | May 15 05:59 PM | Szalay Aladar | 10% Owner | May 08 '24 | Sale | 3.82 | 13,919 | 53,189 | 1,175,787 | May 09 04:38 PM | Szalay Aladar | 10% Owner | May 07 '24 | Sale | 3.67 | 6,025 | 22,111 | 1,189,706 | May 09 04:38 PM | Szalay Aladar | 10% Owner | May 01 '24 | Sale | 3.30 | 33,061 | 109,161 | 1,195,731 | May 01 06:16 PM | Szalay Aladar | 10% Owner | Apr 30 '24 | Sale | 3.12 | 20,535 | 63,981 | 1,228,792 | May 01 06:16 PM | Szalay Aladar | 10% Owner | Apr 29 '24 | Sale | 3.25 | 6,403 | 20,792 | 1,249,327 | May 01 06:16 PM | Szalay Aladar | 10% Owner | Apr 23 '24 | Sale | 3.49 | 22,000 | 76,800 | 1,263,794 | Apr 24 05:50 PM | Szalay Aladar | 10% Owner | Apr 22 '24 | Sale | 3.53 | 14,331 | 50,597 | 1,285,794 | Apr 24 05:50 PM | Szalay Aladar | 10% Owner | Apr 24 '24 | Sale | 3.50 | 8,064 | 28,251 | 1,255,730 | Apr 24 05:50 PM | Szalay Aladar | 10% Owner | Apr 16 '24 | Sale | 3.53 | 48,683 | 171,802 | 1,322,862 | Apr 18 05:00 PM | Szalay Aladar | 10% Owner | Apr 17 '24 | Sale | 3.71 | 22,737 | 84,425 | 1,300,125 | Apr 18 05:00 PM | Yu Yong | VP, Clinical Trial Operations | Dec 15 '23 | Sale | 13.16 | 32,535 | 428,180 | 0 | Dec 18 04:15 PM | Tyree James L | Director | Dec 13 '23 | Sale | 13.22 | 9,000 | 118,969 | 3,460 | Dec 14 08:59 PM | Thomas John | Director | Dec 13 '23 | Sale | 13.38 | 9,000 | 120,387 | 463,460 | Dec 14 08:58 PM | Yu Yong | VP, Clinical Trial Operations | Dec 07 '23 | Sale | 11.85 | 36,800 | 435,995 | 32,535 | Dec 08 05:57 PM | Yu Yong | VP, Clinical Trial Operations | Nov 21 '23 | Sale | 10.26 | 18,665 | 191,555 | 69,335 | Nov 22 04:15 PM | Szalay Aladar | 10% Owner | Oct 25 '23 | Sale | 19.40 | 5,704 | 110,638 | 1,371,545 | Oct 26 05:07 PM | Szalay Aladar | 10% Owner | Oct 23 '23 | Sale | 19.97 | 49,987 | 998,365 | 1,377,249 | Oct 25 04:51 PM | Yu Yong | VP, Clinical Trial Operations | Oct 24 '23 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Oct 25 04:15 PM | Yu Yong | VP, Clinical Trial Operations | Oct 24 '23 | Sale | 19.11 | 5,200 | 99,351 | 106,135 | Oct 25 04:15 PM | Thomas John | Director | Oct 16 '23 | Sale | 20.71 | 3,333 | 69,038 | 472,460 | Oct 16 06:39 PM |
|